News

Endpoints News4h
Ver­tex touts promis­ing first few months of launch for non-opi­oid pain drug Jour­navx
Vertex said it's gathering momentum with its new product launches, building out new franchises with its sickle cell therapy ...
Endpoints News6h
New opi­oid da­ta may not be gen­er­al­iz­able, FDA ad­comm says
Several members of an FDA advisory committee warned on Monday that new data from studies on long-term use of opioids might ...
Endpoints News11h
Func­tion buys Ezra, cre­at­ing one-stop shop for pre­ven­tive test­ing and scans
Function Health is buying Ezra in a bid to create a haven for people who want copious amounts of data on their bodies. The ...
Endpoints News8h
Bris­tol My­ers Squibb to lay off over 500 work­ers in New Jer­sey
Bristol Myers Squibb is letting go of 516 workers in New Jersey as part of a wide-reaching cost-cutting plan aimed at making ...
Endpoints News17h
Ear­ly bits of in vi­vo CAR-T hu­man da­ta emerge from biotech tri­als in Chi­na
Initial clinical data from Genocury and EsoBiotec shows promise for in vivo CAR-T therapy, with complete remission in ...
Endpoints News16h
Ex­clu­sive: Deer­field se­cures $600M+ for third health­care ven­ture fund to seed new com­pa­nies
Deerfield Management is back with its third healthcare venture fund, this time securing more than $600 million to create new ...
Endpoints News17h
In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges
Not many would argue that Biotech is one of the riskiest industries on the globe. With costs hovering in the hundreds of millions of dollars, competitors ...